Skip to content

The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02078583
Enrollment
100
Registered
2014-03-05
Start date
2014-07-31
Completion date
Unknown
Last updated
2014-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Brief summary

Benzodiazepines is a commonly uesd sedative medication,there are many reports that Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines requirements .The purpose of this study is to determine whether analgesia based sedation protocol reduces the incident of delirium.

Interventions

DRUGFentanyl
DRUGRemifentanil
DRUGNormal saline

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Signing a consent form * postoperative patient * Requirement for mechanical ventilation and anticipate time of mechanical ventilation more than 24 hours * Requirement for sedation * Age more than 18 and less than 85 years old

Exclusion criteria

* Unstable blood circulation * Heart rate less than 50 beats per minute * II ° ~ III ° atrioventricular conduct block * Intracranial lesions 、neurosurgical intervention and mental disability inability to cooperate; * Receipt of antipsychotics 、hypnotic drugs before surgery ; * Alcohol abuse; * Liver failure class Child-Pugh C; * Acute Respiratory Distress Syndrome; * Acute or chronic renal failure; * Other severe diseases ,septic shock; * Receipt of neuromuscular blocking drug; * Pregnancy and nursing woman; * Allergy to investigational drug or other contraindication.

Design outcomes

Primary

MeasureTime frame
The incidence and duration of delirium in patients with different regimens1 day

Secondary

MeasureTime frameDescription
Length of ICU stayan expected average of 7 days
Mortality28 days
Ventilator-free daysan expected average of 7 days
Index of anesthesia depth monitoringFrom admission to ICU to weaning,about 7 daysAnalgesic level、sedation level、brain function、 blood perfusion for peripheral and brain circulation、sleep stages and variation of blood volume
Mean days of mechanical ventilationan expected average of 7 days
Plasma melatonin levelEvery 6 hours during the next ICU day
Total rescue dose of midazolamSeven days after giving midazolam to patient
Variations of HR、RR、BP、SpO2an expected average of 7 days
Infusion velocity and total dose of sedative drugs in different groupsFrom admission to ICU to extubation or drug withdrawal,about 7 days

Contacts

Primary ContactDan Liu, Resident physician
fancyjuice@126.com+8613811365572

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026